Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis

NCT00217022 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Study closed early, because of low enrollment.

Conditions

Lymphocytic Colitis
Diarrhea

Interventions

OTHER: Placebo
DRUG: Budesonide

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]